PEMAZYRE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50881-026 -
Package NDC
50881-026-01 -
Application number
NDA213736 -
SPL ID
7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3 -
SPL set ID
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4 -
UNII
Y6BX7BL23K -
RxCUI
2359334 -
RxCUI
2359340 -
RxCUI
2359342 -
RxCUI
2359344 -
RxCUI
2359346 -
RxCUI
2359348
What the source publishes
- Labeler
- Incyte Corporation
- Active ingredients
- pemigatinib
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "PEMAZYRE",
"splId": "7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3",
"labels": [
{
"setId": "9e1f2222-1d89-4e63-989c-ccebe2ab1eb4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e1f2222-1d89-4e63-989c-ccebe2ab1eb4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e1f2222-1d89-4e63-989c-ccebe2ab1eb4"
}
],
"routes": [
"ORAL"
],
"labeler": "Incyte Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "14 TABLET in 1 BOTTLE, PLASTIC (50881-026-01)",
"package_ndc": "50881-026-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20200417"
}
],
"productId": "50881-026_7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "50881-026",
"deaSchedule": null,
"genericName": "pemigatinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PEMIGATINIB",
"strength": "4.5 mg/1"
}
],
"applicationNumber": "NDA213736",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200417",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000175082",
"N0000185503",
"N0000187061",
"N0000191423"
],
"unii": [
"Y6BX7BL23K"
],
"rxcui": [
"2359334",
"2359340",
"2359342",
"2359344",
"2359346",
"2359348"
],
"spl_set_id": [
"9e1f2222-1d89-4e63-989c-ccebe2ab1eb4"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Kinase Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Organic Cation Transporter 2 Inhibitors [MoA]",
"Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
],
"manufacturer_name": [
"Incyte Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50881-026_7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3"